Spectral Medical Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EDTXF research report →
About the company
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
- CEO
- Chris Seto
- IPO
- 2009
- Employees
- 29
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $259.53M
- P/E
- -9.74
- P/S
- 141.34
- P/B
- -5.51
- EV/EBITDA
- -11.66
- Div Yield
- 0.00%
- Gross Margin
- -79.25%
- Op Margin
- -412.28%
- Net Margin
- -1377.18%
- ROE
- 61.00%
- ROIC
- 26.25%
- Revenue
- $2.44M · 6.74%
- Net Income
- $-47,653,133 · -209.40%
- EPS
- $-0.16 · -190.91%
- Op Income
- $-11,675,477
- FCF YoY
- -9.88%
- 52W High
- $1.31
- 52W Low
- $0.58
- 50D MA
- $1.00
- 200D MA
- $1.00
- Beta
- 0.21
- Avg Volume
- 7.36K
Get TickerSpark's AI analysis on EDTXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EDTXF coverage
Recent articles, reports, and earnings notes.
No research on EDTXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EDTXF report →Similar companies
Peers in the same neighborhood.